Related Experiment Videos
Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study.
Naomi M Simon1, Stephen W Parker, Mara Wernick-Robinson
1Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, WACC 815, Boston, MA 02114, USA. nsimon@partners.org
Psychosomatics
|July 8, 2005
Summary
Selective serotonin reuptake inhibitors like fluoxetine may help reduce anxiety and dizziness symptoms in patients with vestibular dysfunction. Further research is needed to clarify effects on balance and vestibular function.
Area of Science:
- Neurology
- Psychiatry
- Otolaryngology
Background:
- Anxiety disorders can worsen symptoms and functional impairment in individuals with vestibular dysfunction.
- Inner ear problems often coexist with and are exacerbated by anxiety.
Purpose of the Study:
- To investigate the efficacy of fluoxetine in treating patients with co-occurring vestibular dysfunction and anxiety.
- To assess the impact of fluoxetine on anxiety levels, dizziness-related impairment, and vestibular function.
Main Methods:
- A prospective study involving five patients with inner ear vestibular dysfunction and anxiety.
- Treatment with fluoxetine (20-60 mg/day) for 12 weeks.
- Comprehensive assessments of anxiety, dizziness impairment, balance, and vestibular function at baseline and after treatment.
Main Results:
- Fluoxetine treatment resulted in significant or near-significant reductions in anxiety measures.
- Patients reported notable improvements in dizziness-related functional impairment.
- Observed improvements in clinical balance and objective vestibular function were less conclusive.
Conclusions:
- Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine, show promise in managing dizziness and anxiety symptoms.
- SSRIs may offer a therapeutic option for patients experiencing combined vestibular dysfunction and anxiety.
- Further investigation is warranted to fully elucidate the effects of SSRIs on vestibular and balance functions.